Insurance - Brokers
Compare Stocks
5 / 10Stock Comparison
TIRX vs ACMR vs ICHR vs UCTT vs MKSI
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
Hardware, Equipment & Parts
TIRX vs ACMR vs ICHR vs UCTT vs MKSI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Insurance - Brokers | Semiconductors | Semiconductors | Semiconductors | Hardware, Equipment & Parts |
| Market Cap | $240K | $3.92B | $2.47B | $3.63B | $20.25B |
| Revenue (TTM) | $8M | $901M | $959M | $2.07B | $4.07B |
| Net Income (TTM) | $-859K | $94M | $-51M | $-194M | $327M |
| Gross Margin | 23.0% | 44.4% | 11.3% | 15.6% | 45.2% |
| Operating Margin | -31.7% | 12.1% | -3.8% | -5.3% | 14.8% |
| Forward P/E | — | 29.7x | 62.2x | 34.4x | 30.4x |
| Total Debt | $1M | $303M | $186M | $810M | $4.69B |
| Cash & Equiv. | $297K | $766M | $98M | $312M | $675M |
TIRX vs ACMR vs ICHR vs UCTT vs MKSI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 21 | Apr 26 | Return |
|---|---|---|---|
| Tian Ruixiang Holdi… (TIRX) | 100 | 0.0 | -100.0% |
| ACM Research, Inc. (ACMR) | 100 | 185.6 | +85.6% |
| Ichor Holdings, Ltd. (ICHR) | 100 | 131.7 | +31.7% |
| Ultra Clean Holding… (UCTT) | 100 | 157.2 | +57.2% |
| MKS Inc. (MKSI) | 100 | 154.7 | +54.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TIRX vs ACMR vs ICHR vs UCTT vs MKSI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TIRX is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 158.7%, EPS growth 36.8%, 3Y rev CAGR 4.9%
- Lower volatility, beta 1.16, Low D/E 3.5%, current ratio 6.74x
- Beta 1.16, current ratio 6.74x
- 158.7% revenue growth vs UCTT's -2.1%
ACMR carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 30.7% 10Y total return vs UCTT's 13.9%
- Lower P/E (29.7x vs 30.4x)
- 10.4% margin vs TIRX's -11.1%
- 3.9% ROA vs TIRX's -14.2%, ROIC 7.0% vs -10.4%
ICHR ranks third and is worth considering specifically for momentum.
- +329.1% vs TIRX's -99.9%
Among these 5 stocks, UCTT doesn't own a clear edge in any measured category.
MKSI is the clearest fit if your priority is income & stability.
- Dividend streak 0 yrs, beta 2.64, yield 0.3%
- 0.3% yield, vs ACMR's 0.2%, (3 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 158.7% revenue growth vs UCTT's -2.1% | |
| Value | Lower P/E (29.7x vs 30.4x) | |
| Quality / Margins | 10.4% margin vs TIRX's -11.1% | |
| Stability / Safety | Beta 1.16 vs ICHR's 3.93, lower leverage | |
| Dividends | 0.3% yield, vs ACMR's 0.2%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +329.1% vs TIRX's -99.9% | |
| Efficiency (ROA) | 3.9% ROA vs TIRX's -14.2%, ROIC 7.0% vs -10.4% |
TIRX vs ACMR vs ICHR vs UCTT vs MKSI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
TIRX vs ACMR vs ICHR vs UCTT vs MKSI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TIRX leads in 2 of 6 categories
ACMR leads 2 • ICHR leads 0 • UCTT leads 0 • MKSI leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
TIRX leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MKSI is the larger business by revenue, generating $4.1B annually — 524.5x TIRX's $8M. ACMR is the more profitable business, keeping 10.4% of every revenue dollar as net income compared to TIRX's -11.1%. On growth, TIRX holds the edge at +21.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $8M | $901M | $959M | $2.1B | $4.1B |
| EBITDAEarnings before interest/tax | -$2M | $126M | -$11M | -$52M | $945M |
| Net IncomeAfter-tax profit | -$858,880 | $94M | -$51M | -$194M | $327M |
| Free Cash FlowCash after capex | $2M | -$69M | -$17M | -$44M | $401M |
| Gross MarginGross profit ÷ Revenue | +23.0% | +44.4% | +11.3% | +15.6% | +45.2% |
| Operating MarginEBIT ÷ Revenue | -31.7% | +12.1% | -3.8% | -5.3% | +14.8% |
| Net MarginNet income ÷ Revenue | -11.1% | +10.4% | -5.3% | -9.4% | +8.0% |
| FCF MarginFCF ÷ Revenue | +21.3% | -7.6% | -1.7% | -2.1% | +9.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +21.6% | +9.4% | +4.7% | +2.9% | +15.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +92.3% | -76.1% | +46.2% | -2.6% | +53.2% |
Valuation Metrics
TIRX leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 43.2x trailing earnings, ACMR trades at a 37% valuation discount to MKSI's 68.8x P/E. On an enterprise value basis, MKSI's 26.7x EV/EBITDA is more attractive than UCTT's 34.5x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $240,371 | $3.9B | $2.5B | $3.6B | $20.2B |
| Enterprise ValueMkt cap + debt − cash | $1M | $3.5B | $2.6B | $4.1B | $24.3B |
| Trailing P/EPrice ÷ TTM EPS | -0.06x | 43.21x | -46.25x | -19.98x | 68.83x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 29.68x | 62.25x | 34.44x | 30.36x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.22x | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 27.49x | — | 34.53x | 26.70x |
| Price / SalesMarket cap ÷ Revenue | 0.07x | 4.35x | 2.61x | 1.77x | 5.15x |
| Price / BookPrice ÷ Book value/share | 0.01x | 2.06x | 3.67x | 4.62x | 7.49x |
| Price / FCFMarket cap ÷ FCF | 0.27x | — | — | 247.26x | 40.74x |
Profitability & Efficiency
ACMR leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
MKSI delivers a 12.2% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-25 for UCTT. TIRX carries lower financial leverage with a 0.03x debt-to-equity ratio, signaling a more conservative balance sheet compared to MKSI's 1.73x. On the Piotroski fundamental quality scale (0–9), MKSI scores 6/9 vs ACMR's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -12.0% | +6.1% | -7.5% | -25.4% | +12.2% |
| ROA (TTM)Return on assets | -14.2% | +3.9% | -5.2% | -11.0% | +3.7% |
| ROICReturn on invested capital | -10.4% | +7.0% | -3.9% | +2.6% | +6.5% |
| ROCEReturn on capital employed | -14.0% | +6.6% | -4.7% | +2.9% | +7.2% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 2 | 3 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.03x | 0.16x | 0.28x | 1.03x | 1.73x |
| Net DebtTotal debt minus cash | $881,311 | -$463M | $87M | $499M | $4.0B |
| Cash & Equiv.Liquid assets | $297,288 | $766M | $98M | $312M | $675M |
| Total DebtShort + long-term debt | $1M | $303M | $186M | $810M | $4.7B |
| Interest CoverageEBIT ÷ Interest expense | — | 20.44x | -5.97x | -5.80x | 2.84x |
Total Returns (Dividends Reinvested)
ACMR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ACMR five years ago would be worth $23,344 today (with dividends reinvested), compared to $0 for TIRX. Over the past 12 months, ICHR leads with a +329.1% total return vs TIRX's -99.9%. The 3-year compound annual growth rate (CAGR) favors ACMR at 80.5% vs TIRX's -95.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -98.1% | +31.9% | +249.0% | +192.5% | +78.8% |
| 1-Year ReturnPast 12 months | -99.9% | +195.6% | +329.1% | +312.7% | +306.1% |
| 3-Year ReturnCumulative with dividends | -100.0% | +487.9% | +151.1% | +187.5% | +266.0% |
| 5-Year ReturnCumulative with dividends | -100.0% | +133.4% | +28.9% | +59.4% | +66.5% |
| 10-Year ReturnCumulative with dividends | -100.0% | +3065.8% | +629.1% | +1385.1% | +750.6% |
| CAGR (3Y)Annualised 3-year return | -95.0% | +80.5% | +35.9% | +42.2% | +54.1% |
Risk & Volatility
Evenly matched — TIRX and ICHR each lead in 1 of 2 comparable metrics.
Risk & Volatility
TIRX is the less volatile stock with a 1.16 beta — it tends to amplify market swings less than ICHR's 3.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ICHR currently trades 97.7% from its 52-week high vs TIRX's 0.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.16x | 3.24x | 3.93x | 3.19x | 2.64x |
| 52-Week HighHighest price in past year | $10.75 | $71.65 | $72.87 | $87.68 | $326.83 |
| 52-Week LowLowest price in past year | $0.00 | $19.26 | $13.12 | $18.52 | $71.49 |
| % of 52W HighCurrent price vs 52-week peak | +0.1% | +82.6% | +97.7% | +91.1% | +92.0% |
| RSI (14)Momentum oscillator 0–100 | 40.4 | 60.7 | 66.9 | 62.3 | 65.3 |
| Avg Volume (50D)Average daily shares traded | 11.4M | 1.2M | 795K | 1.3M | 1.2M |
Analyst Outlook
Evenly matched — ACMR and MKSI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ACMR as "Buy", ICHR as "Buy", UCTT as "Buy", MKSI as "Buy". Consensus price targets imply 6.4% upside for UCTT (target: $85) vs -32.4% for ACMR (target: $40). For income investors, MKSI offers the higher dividend yield at 0.29% vs ACMR's 0.19%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $40.00 | $49.80 | $85.00 | $272.86 |
| # AnalystsCovering analysts | — | 10 | 14 | 12 | 29 |
| Dividend YieldAnnual dividend ÷ price | — | +0.2% | — | — | +0.3% |
| Dividend StreakConsecutive years of raises | — | 3 | 1 | 1 | 0 |
| Dividend / ShareAnnual DPS | — | $0.11 | — | — | $0.87 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.2% | 0.0% | +0.1% | +0.2% |
TIRX leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). ACMR leads in 2 (Profitability & Efficiency, Total Returns). 2 tied.
TIRX vs ACMR vs ICHR vs UCTT vs MKSI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is TIRX or ACMR or ICHR or UCTT or MKSI a better buy right now?
For growth investors, Tian Ruixiang Holdings Ltd (TIRX) is the stronger pick with 158.
7% revenue growth year-over-year, versus -2. 1% for Ultra Clean Holdings, Inc. (UCTT). ACM Research, Inc. (ACMR) offers the better valuation at 43. 2x trailing P/E (29. 7x forward), making it the more compelling value choice. Analysts rate ACM Research, Inc. (ACMR) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TIRX or ACMR or ICHR or UCTT or MKSI?
On trailing P/E, ACM Research, Inc.
(ACMR) is the cheapest at 43. 2x versus MKS Inc. at 68. 8x. On forward P/E, ACM Research, Inc. is actually cheaper at 29. 7x.
03Which is the better long-term investment — TIRX or ACMR or ICHR or UCTT or MKSI?
Over the past 5 years, ACM Research, Inc.
(ACMR) delivered a total return of +133. 4%, compared to -100. 0% for Tian Ruixiang Holdings Ltd (TIRX). Over 10 years, the gap is even starker: ACMR returned +30. 7% versus TIRX's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TIRX or ACMR or ICHR or UCTT or MKSI?
By beta (market sensitivity over 5 years), Tian Ruixiang Holdings Ltd (TIRX) is the lower-risk stock at 1.
16β versus Ichor Holdings, Ltd. 's 3. 93β — meaning ICHR is approximately 239% more volatile than TIRX relative to the S&P 500. On balance sheet safety, Tian Ruixiang Holdings Ltd (TIRX) carries a lower debt/equity ratio of 3% versus 173% for MKS Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — TIRX or ACMR or ICHR or UCTT or MKSI?
By revenue growth (latest reported year), Tian Ruixiang Holdings Ltd (TIRX) is pulling ahead at 158.
7% versus -2. 1% for Ultra Clean Holdings, Inc. (UCTT). On earnings-per-share growth, the picture is similar: MKS Inc. grew EPS 55. 5% year-over-year, compared to -869. 2% for Ultra Clean Holdings, Inc.. Over a 3-year CAGR, ACMR leads at 32. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TIRX or ACMR or ICHR or UCTT or MKSI?
ACM Research, Inc.
(ACMR) is the more profitable company, earning 10. 4% net margin versus -123. 8% for Tian Ruixiang Holdings Ltd — meaning it keeps 10. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MKSI leads at 14. 4% versus -144. 3% for TIRX. At the gross margin level — before operating expenses — TIRX leads at 47. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TIRX or ACMR or ICHR or UCTT or MKSI more undervalued right now?
On forward earnings alone, ACM Research, Inc.
(ACMR) trades at 29. 7x forward P/E versus 62. 2x for Ichor Holdings, Ltd. — 32. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for UCTT: 6. 4% to $85. 00.
08Which pays a better dividend — TIRX or ACMR or ICHR or UCTT or MKSI?
In this comparison, MKSI (0.
3% yield), ACMR (0. 2% yield) pay a dividend. TIRX, ICHR, UCTT do not pay a meaningful dividend and should not be held primarily for income.
09Is TIRX or ACMR or ICHR or UCTT or MKSI better for a retirement portfolio?
For long-horizon retirement investors, Ultra Clean Holdings, Inc.
(UCTT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1385% 10Y return). ACM Research, Inc. (ACMR) carries a higher beta of 3. 24 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (UCTT: +1385%, ACMR: +30. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TIRX and ACMR and ICHR and UCTT and MKSI?
These companies operate in different sectors (TIRX (Financial Services) and ACMR (Technology) and ICHR (Technology) and UCTT (Technology) and MKSI (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: TIRX is a small-cap high-growth stock; ACMR is a small-cap high-growth stock; ICHR is a small-cap quality compounder stock; UCTT is a small-cap quality compounder stock; MKSI is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.